Coding for Facial Injections Flashcards
7 cards from real CPCA practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Coding for Facial Injections flashcards as text
Which of the following best describes the National Correct Coding Initiative (NCCI) edit that most commonly affects facial injection coding?
Answer: Bundling of the injection code with evaluation and management when a modifier is not applied
NCCI edits bundle certain procedure codes with E/M services unless Modifier 25 is appended to show a distinct, separately identifiable service.
A patient receives masseter botulinum toxin injections for documented temporomandibular joint (TMJ) disorder. Which ICD-10-CM code best supports medical necessity?
Answer: M26.60 (TMJ disorder, unspecified)
M26.60 classifies temporomandibular joint disorder and provides medical justification for chemodenervation of the masseter muscle.
When reporting botulinum toxin for hyperhidrosis of the face, which CPT code is used?
Answer: 64650
CPT 64650 covers chemodenervation of eccrine glands for treatment of hyperhidrosis, distinct from muscle-targeted chemodenervation codes.
Under Medicare, botulinum toxin injections for cosmetic purposes such as forehead rhytides are classified as:
Answer: Non-covered services excluded from the Medicare benefit
Medicare explicitly excludes cosmetic procedures, including botulinum toxin for wrinkles, from coverage as they lack medical necessity.
What does the place-of-service (POS) code 11 versus POS 22 indicate on a facial injection claim, and why does it matter?
Answer: POS 11 (office) vs. POS 22 (on campus outpatient hospital) affects reimbursement rates and facility fee eligibility
The POS code determines whether a facility fee can be billed separately and affects the applicable fee schedule, which can significantly impact total reimbursement.
A patient requests both dermal filler and neurotoxin injections at the same visit. The physician documents each procedure separately. How should these be reported?
Answer: Report both 11950 (filler) and 64615 (neurotoxin) as separate line items with appropriate diagnoses linked to each
Filler and neurotoxin injections are distinct procedures with separate CPT codes and can be reported together when each is fully documented.
Which of the following scenarios would require an Advance Beneficiary Notice (ABN) for a Medicare patient seeking facial injections?
Answer: When the provider believes Medicare will deny the injection as cosmetic or not medically necessary
An ABN must be issued when Medicare is expected to deny payment so the patient can make an informed decision about financial responsibility.